Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision.

Published

Journal Article (Review)

OBJECTIVES: Several studies have explored posttreatment voice outcomes for early glottic cancer with varying results. To further clarify the voice-related quality of life (QOL) of T1 glottic cancer patients treated by external beam radiotherapy (EBRT) compared to endoscopic carbon dioxide laser excision (CLE), we performed a meta-analysis. METHODS: We performed a meta-analysis review for the years 1966 to 2005 for the Voice Handicap Index (VHI), laryngeal cancer, voice outcome, voice quality, and quality of life. Studies in which the VHI was assessed at least 3 months after treatment for T1 glottic cancer were identified and analyzed by meta-analysis techniques. RESULTS: Six studies with 208 patients (6 T1b and 202 T1a) treated with CLE and 91 patients (6 T1b and 85 T1a) treated with EBRT were identified. The posttreatment VHI scores were similar for the EBRT- and CLE-treated patients (p = .1, Wilcoxon rank sum test). CONCLUSIONS: We conclude that CLE and EBRT provide comparable levels of voice handicap for patients with T1 glottic cancer.

Full Text

Duke Authors

Cited Authors

  • Cohen, SM; Garrett, CG; Dupont, WD; Ossoff, RH; Courey, MS

Published Date

  • August 2006

Published In

Volume / Issue

  • 115 / 8

Start / End Page

  • 581 - 586

PubMed ID

  • 16944656

Pubmed Central ID

  • 16944656

International Standard Serial Number (ISSN)

  • 0003-4894

Digital Object Identifier (DOI)

  • 10.1177/000348940611500803

Language

  • eng

Conference Location

  • United States